My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 126

    1.

    Prostate cancer: screening, diagnosis, and management.

    Garnick MB.

    Ann Intern Med. 1993 May 15;118(10):804-18. Review. Erratum in: Ann Intern Med 1994 Apr 15;120(8):698. PMID: 7682387 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prostate cancer: emerging concepts. Part II.

    Garnick MB, Fair WR.

    Ann Intern Med. 1996 Aug 1;125(3):205-12. Review.PMID: 8686979 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.

    Wilt TJ.

    Semin Urol Oncol. 2002 Feb;20(1):10-7. Review.PMID: 11828353 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prostate cancer: emerging concepts. Part I.

    Garnick MB, Fair WR.

    Ann Intern Med. 1996 Jul 15;125(2):118-25. Review.PMID: 8678366 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

    Nair B, Wilt T, MacDonald R, Rutks I.

    Cochrane Database Syst Rev. 2002;(1):CD003506. Review.PMID: 11869665 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology]

    Villers A, Grosclaude P, Haillot O, Abbou CC, Richard F, Boccon-Gibod L.

    Prog Urol. 1997 Jun;7(3):508-15. French. PMID: 9273082 [PubMed - indexed for MEDLINE]Related articles

    7.

    Methodological issues in studies of the treatment, diagnosis, and etiology of prostate cancer.

    Begg CB.

    Semin Oncol. 1994 Oct;21(5):569-79. Review.PMID: 7939748 [PubMed - indexed for MEDLINE]Related articles

    8.

    Diagnosis, management and screening of early localised prostate cancer.

    Selley S, Donovan J, Faulkner A, Coast J, Gillatt D.

    Health Technol Assess. 1997;1(2):i, 1-96. Review.PMID: 9414541 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pharmacoeconomics of available treatment options for metastatic prostate cancer.

    Zeliadt SB, Penson DF.

    Pharmacoeconomics. 2007;25(4):309-27. Review.PMID: 17402804 [PubMed - indexed for MEDLINE]Related articles

    10.

    Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.

    Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, Badalament R, Kane RA, Mostofi FK.

    Cancer. 1993 Sep 1;72(5):1701-8.PMID: 7688658 [PubMed - indexed for MEDLINE]Related articles

    11.

    Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.

    Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C, Brown A, Garber A, Gere M, Hasselblad V, Wilt T, Ziegler K.

    Evid Rep Technol Assess (Summ). 1999 May;(4):i-x, 1-246, I1-36, passim. Review.PMID: 11098244 [PubMed - indexed for MEDLINE]Related articles

    12.

    Screening and early hormonal treatment of prostate cancer are accumulating strong evidence and support.

    Labrie F.

    Prostate. 2000 May 15;43(3):215-22. Review.PMID: 10797496 [PubMed - indexed for MEDLINE]Related articles

    13.

    Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.

    McNaughton-Collins M, Walker-Corkery E, Barry MJ.

    J Natl Cancer Inst Monogr. 2004;(33):78-101. Review.PMID: 15504921 [PubMed - indexed for MEDLINE]Related articles

    14.

    Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

    Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

    Ann Intern Med. 2008 Mar 18;148(6):435-48. Epub 2008 Feb 4. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888. PMID: 18252677 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml.

    Kundu SD, Grubb RL, Roehl KA, Antenor JA, Han M, Catalona WJ.

    J Urol. 2005 Apr;173(4):1116-20.PMID: 15758718 [PubMed - indexed for MEDLINE]Related articles

    16.

    Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.

    Candas B, Cusan L, Gomez JL, Diamond P, Suburu RE, Lévesque J, Brousseau G, Bélanger A, Labrie F.

    Prostate. 2000 Sep 15;45(1):19-35.PMID: 10960839 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities.

    Kubota Y, Ito K, Imai K, Yamanaka H.

    Prostate. 2002 Mar 1;50(4):262-9.PMID: 11870805 [PubMed - indexed for MEDLINE]Related articles

    18.

    The socioeconomic implications of prostate-specific antigen screening.

    Benoit RM, Naslund MJ.

    Urol Clin North Am. 1997 May;24(2):451-8. Review.PMID: 9126243 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prostate cancer and PSA screening.

    Mameghan H.

    Aust Fam Physician. 1999 Aug;28(8):777-81. Review.PMID: 10495525 [PubMed - indexed for MEDLINE]Related articles

    20.

    Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

    Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD.

    JAMA. 1999 May 5;281(17):1598-604.PMID: 10235152 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity